Aspen Pharmacare. Down 37% From 3rd & Final Sell Call
The final call was on the peak of 29 September. Looking back, good call (hope it helped!).
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
Down 37% From 3rd & Final Sell Call.
Updates 1 to 3 attached.
